| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.02B | +18.1% |
| Gross profit | ¥-0.02B | — |
| Operating income | ¥-0.03B | — |
| Net income | ¥-0.03B | — |
| Gross margin | -78.6% | Net margin -148.6% |
| Revenue Q/Q | -51.4% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.03B | 178.6% |
| SG&A | ¥0.01B | 62.1% |
| Tax & other | ¥0.00B | 1.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
锋尚文化 ・ 美畅股份 ・ 蓝盾光电 ・ 卡倍亿 ・ 南大环境 ・ 大宏立 ・ 圣元环保 ・ 杰美特 ・ 康泰医学 ・ 欧陆通 ・ 回盛生物 ・ 天阳科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies